Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIL1033 in Type 2 Diabetes Mellitus
NCT01406717Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Mar 2013
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Sun Pharma. Started Mar 2013; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01406717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01406717.